Skip to main content

Sleep Disorders News (Page 8)

FDA Approves Hetlioz (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

WASHINGTON, Dec. 1, 2020 /PRNewswire/ – Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Hetlioz (tasimelteon) capsule...

FDA Approves Hetlioz: First Treatment for Non-24 Hour Sleep-Wake Disorder in Blind Individuals

January 31, 2014 – The U.S. Food and Drug Administration today approved Hetlioz (tasimelteon), a melatonin receptor agonist, to treat non-24- hour sleep-wake disorder (“non-24”) in totally blind ind...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Insomnia, Narcolepsy, Drowsiness, Shift Work Sleep Disorder